Computed tomography versus magnetic resonance imaging in high-dose-rate prostate brachytherapy planning: The impact on patient-reported health-related quality of life

This study aimed to compare the patient-reported health-related quality of life (hrQOL) and physician-graded toxicity outcomes of CT-based and MRI-based HDR prostate brachytherapy.

Source: Brachytherapy - November 4, 2020 Category: Cancer & Oncology Authors: Alexander A. Harris, Megan Wu, Jacqueline M. Deirmenjian, Steven M. Shea, Hyejoo Kang, Rakesh Patel, Derek Fielder, Michael L. Mysz, Matthew M. Harkenrider, Abhishek A. Solanki Source Type: research